About Commure
Commure sells AI software to hospitals, health systems and medical practices. Its products handle calls, referrals, clinical notes, coding, claims and payments. The platform connects with more than 60 electronic health record systems.
Commure is based in Mountain View, California, and Tanay Tandon is its chief executive officer. Commure serves more than 500 healthcare organizations across over 3,000 sites. Its platform processes tens of billions of dollars in annual claims. Customers include HCA Healthcare and Tenet Healthcare.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | Oct 27, 2026 | $70,089,315fully sold | 11 | $6.3M | EquityRule 506(b) | Form D ↗ |
| Dec 31, 2021 | Jan 19, 2022 | $3,750,000of $7.5M target | 1 | $3.7M | EquityRule 506(b) | Form D ↗ |
| Sep 13, 2021 | Sep 16, 2021 | $149,999,844of $249.9M target | 3 | $49.9M | EquityRule 506(b) | Form D ↗ |
| Sep 1, 2021 | Sep 16, 2021 | $148,999,979fully sold | 1 | $148.9M | EquityRule 506(b) | Form D ↗ |
| Nov 19, 2020 | Sep 16, 2021 | $210,249,867of $274.2M target | 11 | $19.1M | EquityRule 506(b) | Form D ↗ |
| Sep 1, 2020 | Sep 28, 2020 | $3,297,219fully sold | 1 | $3.2M | EquityRule 506(b) | Form D ↗ |
| Apr 12, 2019 | Apr 26, 2019 | $26,999,978of $29.9M target | 5 | $5.3M | EquityRule 506(b) | Form D ↗ |
| Jun 5, 2018 | Jun 19, 2018 | $24,839,281of $31.9M target | 4 | $6.2M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 27, 2017 | Jan 10, 2018 | $10,000,120of $12.0M target | 1 | $10.0M | EquityRule 506(b) | Form D ↗ |
| Sep 19, 2017 | Sep 28, 2017 | $1,999,999fully sold | 1 | $1.9M | EquityRule 506(b) | Form D ↗ |
| Total, ten offerings | $650,225,602 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Rounds announced by Commure
What the company said publicly about its funding. Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.
| Announced | Round | Amount | Investors | Source |
|---|---|---|---|---|
| May 19, 2026 | Funding | $70M | General Catalyst (lead), Sequoia Capital, Morgan Stanley, and Kirkland & Ellis | commure.com ↗ |
| Jun 19, 2025 | Growth financing | $200M | General Catalyst's Customer Value Fund (lead) | commure.com ↗ |
Why Investors Backed Commure
Investors backed Commure because healthcare providers spend heavily on administrative work. Commure uses one AI platform for calls, notes, coding, claims and payments. More than 500 healthcare organizations use it. General Catalyst led its May 2026 financing at a $7 billion valuation.
The problem it targets
Hospitals and medical practices still depend on people for calls, referrals, documentation, billing and insurance appeals. Commure's view is that this administrative work costs the U.S. healthcare system about $1 trillion each year. Separate tools also leave clinical and financial data split across systems.
What the product does
Commure connects patient access, clinical work and revenue-cycle management. Its software answers calls, processes referrals, drafts clinical notes, assigns codes and works claims. The platform connects with more than 60 electronic health record systems. Commure's revenue-cycle software completes more than 85 percent of work without a person.
Progress so far
Commure operates in more than 500 healthcare organizations across over 3,000 sites. More than 130 large U.S. health systems use the platform, including HCA Healthcare and Tenet Healthcare. Its ambient products support tens of millions of appointments each year. It also processes tens of billions of dollars in annual payments.
Who backs it
General Catalyst has backed Commure since 2017. Its portfolio page names Hemant Taneja and Quentin Clark as the firm's investors in the company. General Catalyst led the $70 million financing announced in May 2026. Sequoia Capital, Morgan Stanley, and Kirkland & Ellis also participated. General Catalyst's Customer Value Fund supplied $200 million in growth financing in June 2025.
How the market is moving
Healthcare AI companies are expanding from clinical notes into patient access and billing. Commure launched Orchestrator in July 2026 to process referrals and patient intake. The company has also expanded through acquisitions, including Augmedix and Memora Health, according to Fierce Healthcare.
We wrote this summary from public statements by Commure and its investors. It is not investment advice.
Commure in the News
Leadership Team
Executive officers and directors listed on Commure's Form D filed Oct 27, 2026.
Earlier filings also listed Chris Kuhns (executive officer, last listed Jun 2024), Ashwini Zenooz (director, last listed Oct 2023), Karen Tsay (chief financial officer, last listed Jan 2022), Brent Dover (executive officer and director, last listed Sep 2021), Diede van Lamoen (executive officer and director, last listed Sep 2020) and Eugene Kuznetsov (executive officer, last listed Apr 2019).
Sources
- SECCommure, Inc. filing history
- Company siteCommure company page
- InvestorCommure portfolio page at General Catalyst